Funding for this research was provided by:
National Institutes of Health (U42OD011140)
Received: 19 January 2022
Accepted: 12 June 2022
First Online: 21 June 2022
: This is a review of the literature so no actual research was performed, only a review of research.
: All authors consent to the content of the publication.
: The University of Missouri holds intellectual property rights on several the pigs described above that include, but are not limited to, the GalSafe® pigs licensed to Revivicor and the <i>CD163</i> edited pigs licensed to Genus PLC. B.P.T is a founding member and holds financial interest in RenOVAte Biosciences Inc., a livestock genome editing company.